Journal
NEUROBIOLOGY OF DISEASE
Volume 32, Issue 3, Pages 412-419Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2008.08.001
Keywords
Alzheimer; Amyloid; Microglia; PIB; PK11195; PET
Categories
Funding
- Medical Research Council (MRC)
- Alzheimers Research UK [ART-PPG2004A-3, ART-EG2003B-2] Funding Source: researchfish
- Medical Research Council [G84/6523, G0601846, G108/585, MC_U120085814, MC_U120036861] Funding Source: researchfish
- MRC [G84/6523, G0601846, MC_U120085814, G108/585, MC_U120036861] Funding Source: UKRI
Ask authors/readers for more resources
[11C](R)PK11195-PET is a marker of activated microglia while [11C]PIB-PET detects raised amyloid load. Here we studied in vivo the distributions of amyloid load and microglial activation in Alzheimer's disease (AD) and their relationship with cognitive status. Thirteen AD subjects had [11C](R)PK11195-PET and [11C]PIB-PET scans. Ten healthy controls had [11CI(R)PK]1195-PET and 14 controls had [11C]PIB-PET scans. Region-of-interest analysis of [11C](R)PK11195-PET detected significant 20-35% increases in microglial activation in frontal, temporal, parietal, occipital and cingulate cortices (p<0.05)of the AD subjects. [11C]PIB-PET revealed significant two-fold increases in amyloid load in these same cortical areas (p<0.0001) and SPM (statistical parametric mapping) analysis confirmed the localisation of these increases to association areas. MMSE scores in AD subjects correlated with levels of cortical microglial activation but not with amyloid load. The inverse correlation between MMSE and microglial activation is compatible with a role of microglia in neuronal damage. (C) 2008 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available